Blueprint Medicines Corpo... (BPMC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
106.12
3.56 (3.47%)
At close: Jan 15, 2025, 11:38 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
PE Ratio | -11.02 | -4.69 | -9.73 | 19.48 | -11.66 | -9.99 | -19.24 | -10.64 | -9.1 | -6.13 | -11.81 |
PS Ratio | 22.40 | 12.81 | 34.81 | 7.71 | 57.61 | 53.12 | 133.01 | 27.77 | 42.13 | n/a | n/a |
PB Ratio | 42.77 | 5.08 | 6.46 | 4.16 | 8.25 | 5.64 | 4.57 | 3.62 | 3.34 | 6.97 | -165.02 |
P/FCF Ratio | -12.33 | -5.11 | -11.19 | 15.93 | -13.12 | -12.6 | -21.05 | -28.7 | -13.14 | -6.84 | -12.8 |
P/OCF Ratio | -12.79 | -5.2 | -20.99 | 15.80 | -13.78 | -13.51 | -23.78 | -31.46 | -15.16 | -6.97 | -12.98 |
OCF/S Ratio | -1.75 | -2.46 | -1.66 | 0.49 | -4.18 | -3.93 | -5.59 | -0.88 | -2.78 | n/a | n/a |
Debt / Equity Ratio | 5.93 | 0.47 | 0.11 | 0.06 | 0.21 | 0.03 | 0.03 | 0.02 | 0.03 | 0.26 | -1.91 |
Quick Ratio | 3.66 | 5.55 | 3.55 | 7.03 | 8.93 | 8.29 | 15.98 | 9.63 | 9.14 | 7.14 | 0.78 |
Current Ratio | 3.76 | 5.71 | 3.70 | 7.09 | 4.85 | 8.29 | 15.98 | 7.73 | 9.14 | 7.14 | 0.78 |
Asset Turnover | 0.24 | 0.15 | 0.14 | 0.46 | 0.09 | 0.08 | 0.03 | 0.10 | 0.06 | n/a | n/a |
Interest Coverage | n/a | -32.76 | n/a | n/a | -26.7 | -3.38K | -676.36 | -156.95 | -76.18 | -87.93 | -150.54 |
Return on Equity (ROE) | -3.88 | -1.08 | -0.66 | 0.21 | -0.71 | -0.56 | -0.24 | -0.34 | -0.37 | -1.14 | 13.98 |
Return on Assets (ROA) | -0.48 | -0.41 | -0.51 | 0.18 | -0.46 | -0.44 | -0.21 | -0.26 | -0.29 | -0.81 | -5.06 |
Return on Capital (ROIC) | -0.58 | -0.47 | -0.59 | 0.19 | -0.61 | -0.51 | -0.22 | -0.29 | -0.33 | -0.92 | -21.15 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 94.87% | 91.27% | 90.04% | 99.95% | 100.00% | -447.2% | -575.29% | -192.13% | -326.21% | n/a | n/a |
Net Profit Margin | -203.3% | -273.24% | -357.67% | 39.54% | -494.2% | -531.53% | -691.3% | -261.04% | -462.89% | n/a | n/a |
Pretax Profit Margin | -202.91% | -270.68% | -356% | 39.68% | -522.75% | -531.53% | -691.3% | -261.04% | -462.89% | n/a | n/a |
Operating Profit Margin | -194.99% | -269.19% | -360.1% | 38.07% | -551.16% | -554.86% | -697.64% | -265.04% | -465.1% | n/a | n/a |
FCF Margin | -181.61% | -250.54% | -310.91% | 48.36% | -439.06% | -421.57% | -631.84% | -96.74% | -320.69% | n/a | n/a |
EBITDA Margin | -188.61% | -252.61% | -348.9% | 38.89% | -535.34% | -545.32% | -698.54% | -253.65% | -448.46% | n/a | n/a |